Signals in asbestos related diseases in human breath - preliminary results

International Journal for Ion Mobility Spectrometry

Volumn 17, Issue 2, 2014, Pages 87-94

  Cakir, Y ^a,b   Metrailler L ^c,e   Baumbach, J I ^c,d   Kraus, T ^b  

^a Knappschaftskrankenhaus Dortmund   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c TU DORTMUND UNIVERSITY   (Germany)

^d REUTLINGEN UNIVERSITY   (Germany)

^e UNIVERSITY OF APPLIED SCIENCES WESTERN SWITZERLAND   (Switzerland)

Author keywords

Asbestos; Breath gas analysis; MCC IMS; Pleural thickening; Pulmonary fibrosis

Indexed keywords

CHROMATOGRAPHIC ANALYSIS; DECISION TREES; ION MOBILITY SPECTROMETERS; MONOTERPENES; NONINVASIVE MEDICAL PROCEDURES;

ASBESTOS-RELATED DISEASE; ION MOBILITY SPECTROMETRY; MCC/IMS; MULTI-CAPILLARY COLUMNS; NEGATIVE PREDICTIVE VALUE; NONINVASIVE METHODS; PLEURAL THICKENING; PULMONARY FIBROSIS;

ASBESTOS;

ASBESTOS; CHROMATOGRAPHY; MONOTERPENES;

EID: 84901855565     PISSN: 14356163     EISSN: 18654584     Source Type: Journal    
DOI: 10.1007/s12127-014-0147-7     Document Type: Article

References (67)

1. Manning CB, Vallyathan V, Mossman BT (2002) Diseases caused by asbestos: mechanisms of injury and disease development. Int Immunopharmacol 2: 191-200.
2. Ross MH, Murray J (2004) Occupational respiratory disease in mining. Occup Med 54: 304-310.
3. Bolton C, Richards A, Ebden P (2002) Asbestos-related disease. Hosp Med 63: 148-151.
4. American Thoracic Society (2004) Diagnosis and initial management of non-malignant diseases related to asbestos. Am J Respir Crit Care Med 170: 691-715.
5. Bundesministerium für Arbeit und Sozialordnung (1991) Merkblatt zur BKNr. 4103: Asbeststaublungenerkrankung (Asbestose) oder durch Asbeststaub verursachte Erkrankung der Pleura. Merkblatt fur die arztliche Untersuchung. Bek. d. BMA v. 13. 05. 1991. BArbBl: 74-76.
6. Bundesministerium für Arbeit und Sozialordnung (1997) Merkblatt zur BK Nr. 4104: Lungenkrebs oder Kehlkopfkrebs in Verbindung mit Asbeststaublungenerkrankung (Asbestose), in Verbindung mit durch Asbeststaub verursachter Erkrankung der Pleura oder bei Nachweis der Einwirkung einer kumulativen Asbestfaserstaub-Dosis am Arbeitsplatz von mindestens 25 Faserjahren (25 × 106 [(Fasern/m3) × Jahre]) Bek. des BMA v. 1. 12. 1997- IVa 4-45206. BArbBl: 32-35.
7. Bundesministerium für Arbeit und Sozialordnung (1994) Merkblatt zur BK Nr. 4105: Durch Asbest verursachtes Mesotheliom des Rippenfells, des Bauchfells oder des Pericards. Merkblatt fur die arztliche Untersuchung. Bek. des BMA v. 8. 11. 1993. BArbBl: 67.
8. Chapman EA, Thomas PS, Yates DH (2010) Breath analysis in asbestos-related disorders: a review of the literature and potential future applications. J Breath Res 4: 034001/034001-034001/034011. doi: 10. 1088/1752-7155/4/3/034001.
9. Diagnostics and Expert Opinion of Asbestos-induced Occupational Diseases (2011) Interdisciplinary Guideline of the German Respiratory Society and the German Society of Occupational and Environmental Medicine, Bibliografie DOI http://dx. doi. org/10. 1055/s-0030-1255992, Online-Publikation: 18. 1. 2011 Pneumologie 2011; 65: e1-e47 © Georg Thieme Verlag KG Stuttgart New York ISSN 0934-8387.
10. Chow S (2009) Non-invasive measurement of markers of oxidative stress in asbestos-related lung diseases and pulmonary fibrosis PhD thesis. The University of New South Wales.
11. King J, Mochalski P, Kupferthaler A, Unterkofler K, Koc H, Filipiak W, Teschl S, Hinterhuber H, Amann A (2010) Dynamic profiles of volatile organic compounds in exhaled breath as determined by a coupled PTR-MS/GC-MS study. Physiol Meas 31: 1169-1184. doi: 10. 1088/0967-3334/31/9/008.
12. Thekedar B, Szymczak W, Hoellriegl V, Hoeschen C, Oeh U (2009) Investigations on the variability of breath gas sampling using PTR-MS. J Breath Res 3: 027007/027001-027007/027011.
13. Schwarz K, Filipiak W, Amann A (2009) Determining concentration patterns of volatile compounds in exhaled breath by PTR-MS. J Breath Res 3: 027002/027001-027002/027015.
14. Lindinger W, Hansel A, Jordan A (1998) Proton-transfer-reaction mass spectrometry (PTR-MS): on-line monitoring of volatile organic compounds at pptv levels. Chem Soc Rev 27: 347-354.
15. Lindinger W, Hansel A, Jordan A (1998) On-line monitoring of volatile organic compounds at pptv levels by means of proton-transfer-reaction mass spectrometry (PTR-MS). - Medical Applications, Food Control and Environmental Research. Int J Mass Spectrom Ion Process 173: 191-241.
16. Hornuss C, Wiepcke D, Praun S, Dolch ME, Apfel CC, Schelling G (2012) Time course of expiratory propofol after bolus injection as measured by ion molecule reaction mass spectrometry. Anal Bioanal Chem 403: 555-561. doi: 10. 1007/s00216-012-5856-3.
17. Tegtmeyer U, Weiss HP, Schlägl HP (1993) Gas analysis by IMR-MS: a comparison to conventional mass spectrometry. Fresenius J Anal Chem 347: 263-268.
18. Belda-Iniesta C et al (2007) New screening method for lung cancer by detecting volatile organic compounds in breath. Clin Transl Oncol Field 9: 364-368.
19. Cheng ZJ, Warwick G, Yates DH, Thomas PS (2009) An electronic nose in the discrimination of breath from smokers and non-smokers: a model for toxin exposure. J Breath Res 3: 036003/036001-036003/036005.
20. Machado Roberto F et al (2005) Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med 171: 1286-1291.
21. Guaman AV, Carreras A, Calvo D, Agudo I, Navajas D, Pardo A, Marco S, Farre R (2012) Rapid detection of sepsis in rats through volatile organic compounds in breath. J Chromatogr B Anal Technol Biomed Life Sci 881-882: 76-82.
22. Kushch I et al (2008) Compounds enhanced in a mass spectrometric profile of smokers' exhaled breath versus non-smokers as determined in a pilot study using PTR-MS. J Breath Res 2: 026002/026001-026002/026026.
23. Miekisch W, Schubert JK, Vagts DA, Geiger K (2001) Analysis of volatile disease markers in blood. Clin Chem 47: 1053-1060.
24. Buchinger H, Kreuer S, Hellbrück R, Wolf A, Fink T, Volk T, Bödeker B, Maddula S, Baumbach JI (2013) Minimal retarded Propofol signals in human breath using ion mobility spectrometry. Int J Ion Mobil Spectrom 16: 191-198.
25. Zhou Q, Wang W, Cang H, Du Y, Han F, Chen C, Cheng S, Li J, Li H (2012) On-line measurement of propofol using membrane inlet ion mobility spectrometer. Talanta 98: 241-246. doi: 10. 1016/j. talanta. 2012. 07. 001.
26. Kreuder A-E, Buchinger H, Kreuer S, Volk T, Maddula S, Baumbach JI (2011) Characterization of propofol in human breath of patients undergoing anesthesia. Int J Ion Mobil Spectrom 14: 167-175. doi: 10. 1007/s12127-011-0080-y.
27. Perl T, Carstens E, Hirn A, Quintel M, Vautz W, Nolte J, Junger M (2009) Determination of serum propofol concentrations by breath analysis using ion mobility spectrometry. Br J Anaesth 103: 822-827. doi: 10. 1093/bja/aep312.
28. Baumbach JI (2009) Ion mobility spectrometry coupled with multi-capillary columns for metabolic profiling of human breath. J Breath Res 3: 1-16.
29. Hauschild A-C, Kopczynski D, D'Addario M, Baumbach JI, Rahmann S, Baumbach J (2013) Peak detection method evaluation for ion mobility spectrometry by using machine learning approaches. Metabolites 3: 277-293.
30. Cumeras R, Figueras E, Gracia I, Maddula S, Baumbach JI (2013) What is a good control group? Int J Ion Mobil Spectrom 16: 1-8.
31. Jünger M, Vautz W, Kuhns M, Hofman L, Ulbricht S, Baumbach JI, Quintel M, Perl T (2012) Ion mobility spectrometry for microbial volatile organic compounds: a new pathogen identification tool by smelling human pathogenic bacteria. Appl Microbiol Biotechnol 93: 2603-2614. doi: 10. 1007/s00253-012-3924-4.
32. Cumeras R, Schneider T, Favrod P, Figueras E, Gracia I, Maddula S, Baumbach JI (2012) Stability and alignment of MCC/IMS devices. Int J Ion Mobil Spectrom 15: 41-46.
33. Cumeras R, Favrod P, Rupp K, Figueras E, Gracia I, Maddula S, Baumbach JI (2012) Influence of operational background emissions on breath analysis using MCC/IMS devices. Int J Ion Mobil Spectrom 15: 69-78. doi: 10. 1007/s12127-012-0094-0.
34. Westhoff M, Litterst P, Maddula S, Bödeker B, Baumbach JI (2011) Statistical and bioinformatical methods to differentiate chronic obstructive pulmonary disease (COPD) including lung cancer from healthy control by breath analysis using ion mobility spectrometr. Int J Ion Mobil Spectrom 11: 139-149. doi: 10. 1007/s12127-011-0081-x.
35. Rabis T, Sommerwerck U, Anhenn O, Darwiche K, Freitag L, Teschler H, Bödeker B, Maddula S, Baumbach JI (2011) Detection of infectious agents in the airways by ion mobility spectrometry of exhaled breath. Int J Ion Mobil Spectrom 11: 187-195. doi: 10. 1007/s12127-011-0077-6.
36. Darwiche K, Baumbach JI, Sommerwerck U, Teschler H, Freitag L (2011) Bronchoscopically obtained Volatile Biomarkers in Lung Cancer. Lung 189: 445-452. doi: 10. 1007/s00408-011-9324-1.
37. Baumbach JI, Maddula S, Sommerwerck U, Besa V, Kurth I, Bödeker B, Teschler H, Freitag L, Darwiche K (2011) Significant different volatile biomarker during bronchoscopic ion mobility spectrometry investigation of patients suffering lung carcinoma. Int J Ion Mobil Spectrom 14: 159-166. doi: 10. 1007/s12127-011-0078-5.
38. Vautz W, Baumbach JI, Westhoff M, Zuechner K, Carstens ETH, Perl T (2010) Breath sampling control for medical application. Int J Ion Mobil Spectrom 13: 41-46.
39. Maddula S, Blank L, Schmid A, Baumbach JI (2009) Detection of volatile metabolites of Escherichia coli by multi capillary column coupled ion mobility spectrometry. Anal Bioanal Chem 394: 791-800.
40. Vautz W, Baumbach JI (2008) Analysis of bio-processes using ion mobility spectrometry. Eng Life Sci 8: 19-25.
41. Baumbach JI (2006) Process analysis using ion mobility spectrometry. Anal Bioanal Chem 384: 1059-1070.
42. Ruzsanyi V, Baumbach JI, Sielemann S, Litterst P, Westhoff M, Freitag L (2005) Detection of human metabolites using multi-capillary columns coupled to ion mobility spectrometers. J Chromatogr A 1084: 145-151.
43. Kusaka Y, Hering KG, Parker JE (2005) International classification of high-resolution computed tomography for occupational and environmental respiratory diseases. Springer, Tokio.
44. Hering KG, Tuengerthal S, Kraus T (2004) Standardisierte CT/HRCT-Klassifikation der Bundesrepublik Deutschland fur arbeits- und umweltbedingte Thoraxerkrankungen. Radiologe 44: 500-511.
45. Hering KG, Kraus T (2005) Coding CT-classification in occupational and environmental respiratory disease (OERD). In: Kusaka Y, Hering KG, Parker JE (eds) International classification of HRCT for occupational and environmental respiratory diseases. Springer, Tokyo, pp 15-23.
46. Hosoda Y (2005) ILO International classification of radiographs of pneumoconioses past, presence and future. In: Kusaka Y, Hering KG, Parker JE (eds) International classification of high-resolution computed tomography for occupational and environmental respiratory diseases. Springer, Tokio.
47. Hosoda Y (2005) ILO International classification of radiographs of pneumoconioses-past, presence and future. In: Kusaka Y, Hering KG, Parker JE (eds) International classification of high-resolution computed tomography for occupational and environmental respiratory diseases. Springer, Tokio.
48. International Labour Office (2002) Guidelines for the use of the ILO international classification of radiographs of pneumoconioses. Rev. 2000. International Labour Office, Geneva.
49. Hering KG (2003) Inhalationsschaden. In: Freyschmidt J, Galanski M (eds) Handbuch diagnostische radiologie. Springer, Thorax, pp 355-394.
50. Bohlig H, Hain E, Valentin H et al (1981) Die Weiterentwicklung der Internationalen Staublungenklassifikation und ihre Konsequenzen fur die arbeitsmedizinischen Vorsorgeuntersuchungen staubgefährdeter Arbeitnehmer (ILO 1980/Bundesrepublik). Prax Pneumol 35: 1075-1154.
51. Jünger M, Bödecker B, Baumbach JI (2010) Peak asignment in multi-capillary column-ion mobility spectrometry using comparative studies with gas chromatography-mass spectrometry for exhaled breath analysis. Anal Bioanal Chem 396: 471-482.
52. Westhoff M, Litterst P, Freitag L, Urfer W, Bader S, Baumbach JI (2009) Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Thorax 64: 744-748.
53. Bunkowski A, Boedeker B, Bader S, Westhoff M, Litterst P, Baumbach JI (2009) MCC/IMS signals in human breath related to sarcoidoses-results of a feasibility study using an automated peak finding procedure. J Breath Res 3: 046001/046001-046001/046010.
54. Westhoff M, Litterst P, Freitag L, Baumbach JI (2007) Ion mobility spectrometry in the diagnosis of sarcoidoses: results of a feasibility study. J Physiol Pharmacol 58: 739-752.
55. Baumbach JI, Westhoff M (2006) Ion mobility spectrometry to detect lung cancer an airway infections. Spectrosc Eur 18: 22-27.
56. Ruzsanyi V, Baumbach JI, Eiceman GA (2003) Detection of the mold markers using ion mobility spectrometry. Int J Ion Mobil Spectrom 6: 53-57.
57. Bödeker B, Baumbach JI (2009) Analytical description of IMS-signals. Int J Ion Mobil Spectrom 12: 103-108. doi: 10. 1007/s12127-009-0024-y.
58. Bödeker B, Vautz W, Baumbach JI (2008) Peak finding and referencing in MCC/IMS-data. Int J Ion Mobil Spectrom 11: 83-88.
59. Bödeker B, Vautz W, Baumbach JI (2008) Peak comparison in MCC/IMS-data-searching for potential biomarkers in human breath data. Int J Ion Mobil Spectrom 11: 89-93.
60. Bödeker B, Vautz W, Baumbach JI (2008) Visualisation of MCC/IMS-data. Int J Ion Mobil Spectrom 11: 77-82.
61. Lehtonen H, Oksa P, Lehtimäki L, Sepponen A, Nieminen R, Kankaanranta H, Saarelainen S, Järvenpää R, Uitti J, Moilanen E (2007) Increased alveolar nitric oxide concentration and high levels of leukotriene B4 and 8-isoprostane in exhaled breathcondensate in patients with asbestosis. Thorax 62: 602-607. doi: 10. 1136/thx. 2006. 067868.
62. Phillips M, Herrer J, Krishnan S, Zain M, Greenberg J, Cataneo RN (1999) Variation in volatile organic compounds in the breath of normal humans. J Chromatogr B Biomed Sci Appl 729: 75-88.
63. Libardoni M, Stevens PT, Waite JH, Sacks R (2006) Analysis of human breath samples with a multi-bed sorption trap and comprehensive two-dimensional gas chromatography (GC * GC). J Chromatogr B Anal Technol Biomed Life Sc 842: 13-21.
64. Vautz W, Sielemann S, Baumbach JI (2003) The influence of humidity on the determination of organic trace substances in ambient air using UV ion mobility spectrometry: alpha- and beta-pinene, 3-carene and limonene. Int J Ion Mobil Spectrom 6: 21-29.
65. Liu X, Nacson S, Grigoriev A, Lynds P, Pawliszyn J (2006) A new thermal desorption solid-phase microextraction system for hand-held ion mobility spectrometry. Anal Chim Acta 559: 159-165.
66. Wu J (2009) On-site sample preparation and introduction to ion mobility spectrometry PhD thesis. University of Waterloo.
67. Lai H, Guerra P, Joshi M, Almirall JR (2008) Analysis of volatile components of drugs and explosives by solid phase microextraction-ion mobility spectrometry. J Sep Sci 31: 402-412.